Tulsi (Expanded) for Anti-Inflammatory

Research suggests that Tulsi (Ocimum sanctum/tenuiflorum) possesses anti-inflammatory properties, with the available evidence drawn entirely from review articles, in vitro studies, and animal research rather than dedicated human clinical trials specifically targeting inflammation. Multiple reviews published between 2013 and 2024 consistently attribute anti-inflammatory activity to Tulsi's bioactive compounds — including eugenol, rosmarinic acid, ursolic acid, and luteolin — and one broader systematic review of 24 human studies found favorable outcomes for related conditions like metabolic syndrome and immune function, though inflammation was not always the primary endpoint. Studies indicate that these compounds may work by inhibiting key inflammatory pathways, with some reviews suggesting potential applications in conditions involving chronic inflammation, such as neurological disorders and post-stroke immune responses. However, the evidence base remains largely preclinical and descriptive, and reviewers consistently call for more rigorous, well-controlled human trials to confirm these effects, establish mechanisms, and determine which populations might benefit most.